BioXcel Therapeutics Inc. (BTAI)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.41

-0.56%

After-hours Dec 13, 2024, 05:19 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15
Revenue	1.38M	375.00K	-	-	-	-	-	-	-
Cost of Revenue	1.26M	20.00K	297.00K	188.00K	156.00K	17.00K	1K	-	-
Gross Profit	120.00K	355.00K	-297.00K	-188.00K	-156.00K	-17.00K	-1K	-	-
Operating Income	-171.78M	-159.65M	-106.94M	-82.30M	-33.60M	-19.96M	-4.54M	-2.12M	-636.00K
Interest Income	5.65M	2.53M	4.00K	155.00K	633.00K	-	-	-	-
Pretax Income	-179.05M	-165.76M	-106.93M	-82.17M	-32.97M	-19.27M	-4.54M	-2.12M	-636.00K
Net Income	-179.05M	-171.85M	-106.63M	-82.01M	-32.34M	-19.27M	-4.54M	-2.12M	-636.00K
Selling & General & Admin	83.41M	68.76M	54.23M	24.30M	7.80M	5.40M	1.85M	721.00K	403.00K
Research & Development	84.33M	91.24M	52.71M	57.99M	25.80M	14.56M	2.69M	1.40M	233.00K
Other Expenses	4.16M	-427.00K	-	-	-	-	-	-	-
Operating Expenses	171.90M	160.00M	106.94M	82.30M	33.60M	19.96M	4.54M	2.12M	636.00K
Interest Expense	13.31M	8.21M	40.00K	27.00K	-	-	2.00K	-	-
Selling & Marketing Expenses	19.90M	13.01M	-	-	-	-	-	-	-
Cost & Expenses	173.16M	160.02M	106.94M	82.30M	33.60M	19.96M	4.54M	2.12M	636.00K
Income Tax	-	6.09M	-301.00K	-161.00K	-633.00K	692.00K	-	-2.12M	-
Shares Outstanding (Basic)	29.13M	28.02M	26.37M	21.68M	16.29M	14.57M	15.19M	15.65M	15.94M
Shares Outstanding (Diluted)	29.13M	28.02M	26.37M	21.68M	16.29M	14.57M	15.19M	15.65M	15.94M
EPS (Basic)	-6.15	-6.13	-4.04	-3.78	-1.99	-1.32	-0.3	-0.14	-0.04
EPS (Diluted)	-6.15	-6.13	-4.04	-3.78	-1.99	-1.32	-0.3	-0.14	-0.04
EBITDA	-165.42M	-157.38M	-107.00M	-81.98M	-32.81M	-19.25M	-4.54M	-	-636.00K
Depreciation & Amortization	318.00K	327.00K	297.00K	188.00K	156.00K	17.00K	1K	2.12M	-